The computer-aided drug discovery global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Computer-Aided Drug Discovery Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The computer aided drug discovery market size has grown rapidly in recent years. It will grow from $5.94 billion in 2023 to $6.69 billion in 2024 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to growth in computational power, increasing improvement of molecular modeling, growing demand from the pharmaceutical industry, support from regulatory bodies and collaborations.
The computer aided drug discovery market size is expected to see rapid growth in the next few years. It will grow to $10.83 billion in 2028 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to incorporation of AI and ML into drug discovery processes, shift towards personalized medicine, increasing availability of big data and the development, adoption of cloud-based platforms for CADD, developing novel therapeutics. Major trends in the forecast period include trend towards collaboration between various stakeholders, expansion of AI-driven platforms that offer end-to-end solutions, drug discovery, and product innovations.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report
Scope Of Computer-Aided Drug Discovery Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Computer-Aided Drug Discovery Market Overview
Market Drivers –
The rising prevalence of cancer cases is expected to propel the growth of the computer-aided drug discovery market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and division of abnormal cells in the body. The increasing number of cancer cases is due to several factors such as lifestyle changes and urbanization, environmental pollution, tobacco and alcohol consumption, healthcare access, and awareness. Computer-aided drug discovery can help design drugs targeting cancer cells with particular genetic mutations, paving the way for more personalized and effective cancer therapies. For instance, in May 2024, according to the National Cancer Institute, a US-based agency for cancer research and training, nearly 20 million new cases and 9.7 million cancer-related deaths were reported in 2022. By 2040, these figures are projected to rise significantly, with an estimated 29.9 million new cases and 15.3 million deaths annually. Therefore, the rising prevalence of cancer cases drives the computer-aided drug discovery market.
Market Trends –
Major companies operating in the computer-aided drug discovery (CADD) market are developing innovative solutions such as artificial intelligence in drug discovery to enhance the accuracy, speed, and efficiency of identifying potential drug candidates, optimize lead compounds, and facilitate the development of personalized medicine. Artificial intelligence (AI) in drug discovery refers to applying AI technologies, such as machine learning and deep learning, leveraging advanced algorithms to make discovering and developing new drugs faster, more efficient, and more precise. For instance, in December 2023, Merck KGaA, a Germany-based science and technology company, launched AIDDISONTM, the first software-as-a-service platform that integrates drug discovery and synthesis. Combining generative AI, machine learning, and computer-aided drug design, AIDDISONTM accelerates drug development by virtually screening compounds from over 60 billion chemical targets and recommending optimal synthesis routes. The platform is trained on two decades of pharmaceutical R&D data to identify drug-like candidates with properties like non-toxicity and stability. By incorporating Merck’s SynthiaTM retrosynthesis API, AIDDISONTM optimizes drug manufacturing for efficiency and sustainability, aiming to reduce the cost and time of drug discovery.
The computer-aided drug discovery market covered in this report is segmented –
1) By Type: Structure Based Drug Design, Ligand-Based Drug Design, Sequence-Based Approaches
2) By Therapeutic Area: Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, Other Therapeutic Areas
3) By End User: Pharmaceutical Companies, Biotechnology Companies, Research Laboratories
Get an inside scoop of the computer-aided drug discovery market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19379&type=smp
Regional Insights –
North America was the largest region in the computer-aided drug discovery (CADD) market in 2023. The regions covered in the computer-aided drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the computer-aided drug discovery market are Dassault Systèmes SE, PerkinElmer Inc., Roivant Sciences Ltd., Certara Inc., Schrödinger Inc., XtalPi Inc., Dotmatics Limited, Simulations Plus Inc., ChemAxon Ltd., Exscientia Ltd., Insilico Medicine Inc., Collaborative Drug Discovery Inc., OpenEye Scientific Software Inc., Nimbus Therapeutics LLC, Atomwise Inc., GNS Healthcare Inc., BenevolentAI Limited, EpiVax Inc., Numerate Inc., Cloud Pharmaceuticals Inc., Aris Pharmaceuticals Inc., Cyclica Inc., BioSolveIT GmbH, Chemical Computing Group ULC, InSilicoTrials Technologies S.p.A
Table of Contents
1. Executive Summary
2. Computer-Aided Drug Discovery Market Report Structure
3. Computer-Aided Drug Discovery Market Trends And Strategies
4. Computer-Aided Drug Discovery Market – Macro Economic Scenario
5. Computer-Aided Drug Discovery Market Size And Growth
…..
27. Computer-Aided Drug Discovery Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Read Our Related Reports
https://topprnews.com/military-infrastructure-market-outlook/
https://topprnews.com/orthokeratology-lens-market-trends/
https://topprnews.com/global-precocious-puberty-treatment-market/
https://goodprnews.com/military-infrastructure-market-overview/
https://goodprnews.com/orthokeratology-lens-market-growth/
https://goodprnews.com/precocious-puberty-treatment-market-analysis/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
